Carvolix: Details of share capital and voting rights as of January 31, 2026

Carvolix, a company listed on Euronext Paris, has announced the composition of its share capital and the total number of voting rights as of January 31, 2026. Carvolix's share capital amounts to €5,924,367.50, divided into 59,243,675 shares. The theoretical number of voting rights is 77,009,678, while the number of exercisable voting rights is 76,970,505. These figures allow for the calculation of threshold crossings in accordance with the rules of the French Financial Markets Authority (AMF).

Carvolix, founded by Truffle Capital, is positioning itself in the field of medical technologies by targeting the treatment of structural heart diseases and strokes.